Irrespective of these experimental differences in earlier studies, we clearly unraveled the expansion of naïve Treg cells to be one of the mechanisms leading to an overall expansion of fully functional Treg cells in colorectal cancer patients which was further augmented by IL-2 therapy. The gene discussed is IL2; the disease is colorectal cancer.